Skip to content
November 12, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
The Digital Renaissance: Transforming Archived Tissue into a Gateway for Ethical Drug Discovery the-digital-renaissance-transforming-archived-tissue-into-a-gateway-for-ethical-drug-discovery
  • Chemotherapy and Targeted Therapy

The Digital Renaissance: Transforming Archived Tissue into a Gateway for Ethical Drug Discovery

Muslim October 8, 2026
In the rapidly evolving landscape of preclinical research, a paradigm shift is underway. For decades, the pathology...
Read More Read more about The Digital Renaissance: Transforming Archived Tissue into a Gateway for Ethical Drug Discovery
Bridging the Gap: Tameron Harvell and the Future of Precision Oncology bridging-the-gap-tameron-harvell-and-the-future-of-precision-oncology-2
  • Metastatic Breast Cancer Research

Bridging the Gap: Tameron Harvell and the Future of Precision Oncology

Basiran October 8, 2026
In the rapidly shifting landscape of modern medicine, the intersection of patient advocacy, clinical expertise, and cutting-edge...
Read More Read more about Bridging the Gap: Tameron Harvell and the Future of Precision Oncology
A Rift in Global Health: Examining the Strained Relationship Between the United States and the WHO a-rift-in-global-health-examining-the-strained-relationship-between-the-united-states-and-the-who
  • Global Breast Cancer Awareness

A Rift in Global Health: Examining the Strained Relationship Between the United States and the WHO

Reynand Wu October 8, 2026
In a move that has sent tremors through the landscape of international diplomacy and global health security,...
Read More Read more about A Rift in Global Health: Examining the Strained Relationship Between the United States and the WHO
Bridging the Divide: New National Survey Reveals Urgent Call for Standardized Breast Cancer Care Across Canada bridging-the-divide-new-national-survey-reveals-urgent-call-for-standardized-breast-cancer-care-across-canada-3
  • Global Breast Cancer Awareness

Bridging the Divide: New National Survey Reveals Urgent Call for Standardized Breast Cancer Care Across Canada

Nana Wu October 8, 2026
Executive Summary: A Unified Vision for Patient Care A transformative shift in the Canadian healthcare landscape may...
Read More Read more about Bridging the Divide: New National Survey Reveals Urgent Call for Standardized Breast Cancer Care Across Canada
Unveiling a Cunning Cancer Strategy: How Triple-Negative Breast Cancer Recruits Nerves for Growth and Survival unveiling-a-cunning-cancer-strategy-how-triple-negative-breast-cancer-recruits-nerves-for-growth-and-survival
  • Medical Research and Clinical Trials

Unveiling a Cunning Cancer Strategy: How Triple-Negative Breast Cancer Recruits Nerves for Growth and Survival

Iffa Jayyana October 7, 2026
OKLAHOMA CITY, OK – In a significant breakthrough that redefines our understanding of aggressive cancers, new research...
Read More Read more about Unveiling a Cunning Cancer Strategy: How Triple-Negative Breast Cancer Recruits Nerves for Growth and Survival
ArriVent’s Firmonertinib Fails to Meet Primary Endpoint in NSCLC Trial, Stock Plummets Amidst Competitive Landscape arrivents-firmonertinib-fails-to-meet-primary-endpoint-in-nsclc-trial-stock-plummets-amidst-competitive-landscape
  • Medical Research and Clinical Trials

ArriVent’s Firmonertinib Fails to Meet Primary Endpoint in NSCLC Trial, Stock Plummets Amidst Competitive Landscape

Muslim October 7, 2026
A significant setback for ArriVent BioPharma has sent its stock price into a tailspin, following the disappointing...
Read More Read more about ArriVent’s Firmonertinib Fails to Meet Primary Endpoint in NSCLC Trial, Stock Plummets Amidst Competitive Landscape
Navigating the Intersection: GLP-1 Medications and Breast Cancer – What the Latest Research Reveals navigating-the-intersection-glp-1-medications-and-breast-cancer-what-the-latest-research-reveals
  • Patient Advocacy and Support

Navigating the Intersection: GLP-1 Medications and Breast Cancer – What the Latest Research Reveals

Ammar Sabilarrohman October 7, 2026
By Douglas Feil, Chief Program Officer, National Breast Cancer Foundation (NBCF) The landscape of medical treatment is...
Read More Read more about Navigating the Intersection: GLP-1 Medications and Breast Cancer – What the Latest Research Reveals
Research as the Cure: BCRF Transforms Grand Central Terminal into a Hub of Hope and Science research-as-the-cure-bcrf-transforms-grand-central-terminal-into-a-hub-of-hope-and-science
  • Patient Advocacy and Support

Research as the Cure: BCRF Transforms Grand Central Terminal into a Hub of Hope and Science

Siti Muinah October 7, 2026
NEW YORK — As the morning sun filtered through the iconic arched windows of Grand Central Terminal,...
Read More Read more about Research as the Cure: BCRF Transforms Grand Central Terminal into a Hub of Hope and Science
Strengthening the Lifeline: WHO Director-General’s State Visit to Jordan Highlights Global Health Leadership Amid Crisis strengthening-the-lifeline-who-director-generals-state-visit-to-jordan-highlights-global-health-leadership-amid-crisis
  • Breast Cancer Prevention and Lifestyle

Strengthening the Lifeline: WHO Director-General’s State Visit to Jordan Highlights Global Health Leadership Amid Crisis

Reynand Wu October 7, 2026
Executive Summary: A Diplomatic Mission for Global Health The Director-General of the World Health Organization (WHO), Dr....
Read More Read more about Strengthening the Lifeline: WHO Director-General’s State Visit to Jordan Highlights Global Health Leadership Amid Crisis
The Unraveling of a CRISPR Pioneer: Caribou Biosciences Seeks Strategic Alternatives the-unraveling-of-a-crispr-pioneer-caribou-biosciences-seeks-strategic-alternatives
  • Treatment Innovations

The Unraveling of a CRISPR Pioneer: Caribou Biosciences Seeks Strategic Alternatives

Raul Delapena Setiawan October 7, 2026
The biotech sector—and the high-stakes world of CRISPR gene editing—suffered a significant blow this week as Caribou...
Read More Read more about The Unraveling of a CRISPR Pioneer: Caribou Biosciences Seeks Strategic Alternatives

Posts pagination

Previous 1 … 179 180 181 182 183 184 185 … 886 Next

Recent Posts

  • A Paradigm Shift in Brain Cancer: Rogue DNA Rings Identified as Early Drivers of Aggressive Glioblastoma
  • PepGen’s Groundbreaking DM1 Therapy Shows Unprecedented Splicing Correction, Igniting Investor Confidence and Patient Hope
  • Black Women Forge Sisterhood and Drive Impact in Breast Cancer Fight
  • Argenx Bets Big on “Undruggable” Targets: The Strategic Acquisition of Unnatural Products
  • Advancing Precision Urology: Francis Medical Secures J&J Backing for Oncology Expansion of Vanquish Platform

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

a-paradigm-shift-in-brain-cancer-rogue-dna-rings-identified-as-early-drivers-of-aggressive-glioblastoma
  • Medical Research and Clinical Trials

A Paradigm Shift in Brain Cancer: Rogue DNA Rings Identified as Early Drivers of Aggressive Glioblastoma

Raul Delapena Setiawan November 12, 2026
pepgens-groundbreaking-dm1-therapy-shows-unprecedented-splicing-correction-igniting-investor-confidence-and-patient-hope
  • Medical Research and Clinical Trials

PepGen’s Groundbreaking DM1 Therapy Shows Unprecedented Splicing Correction, Igniting Investor Confidence and Patient Hope

Nila Kartika Wati November 12, 2026
black-women-forge-sisterhood-and-drive-impact-in-breast-cancer-fight
  • Patient Advocacy and Support

Black Women Forge Sisterhood and Drive Impact in Breast Cancer Fight

Basiran November 12, 2026
argenx-bets-big-on-undruggable-targets-the-strategic-acquisition-of-unnatural-products
  • Treatment Innovations

Argenx Bets Big on “Undruggable” Targets: The Strategic Acquisition of Unnatural Products

Nana Wu November 12, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.